Menu Back toSession 6: Future Developments and Projects on Clinical Trial Regulations
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Clinical Trial Regulation Conference
Session 6: Future Developments and Projects on Clinical Trial Regulations
Nick Sykes, MS
- Senior Director, Global Regulatory Affairs
- Pfizer, Inc., United Kingdom
The conduct and management of clinical trials continues to evolve. A number of initiatives and programmes have been established to ensure the regulatory oversight of clinical trials is aligned with the way clinical trials are being conducted and planned. This session will explore some of the ongoing work from some of the initiatives and will discuss how they will help ensure clinical research can continue to be conducted effectively and efficiently.
Developments in ICH
Solange Corriol-Rohou, DrMed, MD, PhD
- Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
- AstraZeneca , France
What has been done in IMI Project (to support Clinical Development)
Magda Chlebus, MA
- Executive Director, Science Policy & Regulatory Affairs
- EFPIA, Belgium
TransCelerate Initiatives to Modernise Clinical Development
Alison Bond, PhD
- Director, Global Regulatory and R&D Policy
- AMGEN, United Kingdom